SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalCutera


Next 10 
From: Harshu Vyas1/12/2024 1:49:23 PM
   of 21
 
Cutera down more than 10% as the momentum shifts back towards the sellers. That's fine but we won't really discuss "market prices" on this thread. Nor will we discuss the short interest or the technicals unless it's relevant.

Rather, the objective of this thread is to discuss the real value of Cutera - breaking up its AviClear and Cutera Core businesses. We will also talk about the management of Cutera and the steps they are taking to turnaround this sick business.

Best,
Harshu Vyas

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas1/30/2024 3:33:13 PM
   of 21
 
Look closer.
We're moving... even though the company's keeping these small wins close to their chest. I'm excited for the next conference call!

Cutera releases AviClear acne device in the UK - Aesthetics Membership (aestheticsjournal.com)

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: Harshu Vyas1/31/2024 6:11:19 AM
   of 21
 
Two things that I haven't really discussed -

1. In the event of a liquidation, convertible debt holders come first. Feel a liquidation is unlikely at this point, but maybe in a year if operations are going awfully, it's something to be aware of.

2. $133m of NOLs - it's unlikely that Cutera ever realise such assets since their marketing spend alone is massive, but if they do, it's incredible for shareholders! And another $15m of untilised tax credits.

Will keep scouring the internet for new news and more hints!

Share RecommendKeepReplyMark as Last Read


To: Harshu Vyas who wrote (2)1/31/2024 6:35:06 PM
From: Harshu Vyas
   of 21
 
For those interested, from what I've gathered UK derms are charging about £4.5k for AviClear.

AviClear Acne Treatment | PHI Clinic London

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/1/2024 11:49:07 AM
   of 21
 
Taylor Harris was CFO of Zeltiq before it was acquired and failed to file timely a 10Q and 10K at that point, too. NT 10-K (sec.gov)

The difference being both were filed in less than two months after the notification. Cutera's 10Q was due over two-and-a-half months ago.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/6/2024 12:58:37 PM
   of 21
 
Ok, so it seems the way CUTR's stock trades is simple. Big % gains on up days and stead losses on losing days. Problem is, that losing days occur all too frequently. Ironically, I had planned to cut my loss today if CUTR broke $2.3/sh.

These sort of setups are dangerous because they're so hard to play. Yesterday I had the impression that it was time to get out - the technicals looked pretty dire. And today the stock's up more than 15%. The chart now looks fine because its now bottomed twice in the last month at ~ $2.39 so there's some support there.

Who knows where this goes? I certainly don't have a clue.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/27/2024 11:21:42 AM
   of 21
 
Cutera maintains its support at the $2.39 (ish) level. Problem, as I see it, is there is lots of resistance around $3 so we're stuck in a range for now. I've read online that earnings come out today (?) but I haven't seen any press release confirming that. It's not on their IR website, either.

Not too sure what to do. The silence is beginning to worry me. Have reached out to IR a few times. No response.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Harshu Vyas who wrote (7)2/28/2024 10:08:58 AM
From: Harshu Vyas
   of 21
 
My concern now is the silence from management and the IR team. No conference call has even been scheduled for 4Q earnings... why? In the prelim results, management said they would meet with investors privately. Does that mean no conference? Are they shrugging off analysts?

They still have to file a 10K and a 10Q, too. This wasn't a concern when I first invested, but it's slowly becoming one the longer this draws out.

I've emailed IR, but they haven't replied to me in the past. If the silence continues, I'll sell at a loss.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Harshu Vyas who wrote (8)2/28/2024 1:22:40 PM
From: Harshu Vyas
   of 21
 
Welp. It's broken support and we're into the $2.2s... what does the market know?

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas2/29/2024 10:38:51 AM
   of 21
 
Jeez, this stock is like a toxic girlfriend. No stability and a constant headache.

I don't recommend the stock... Even if it is undervalued. It's just not worth the pain. But I'm underwater and selling at a loss for no reason is stupid, so here I stubbornly remain.

Average price is $2.5. I sold my VFC shares last night to add. No excess cash. I'm all-in. And I just can't wait to get out and pick up my VFC shares again. Oh, how much I'd give to own quality companies!

Share RecommendKeepReplyMark as Last Read
Next 10